High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 107-112

  Sfondrini, Lucia ^a   Morelli, Daniele ^a   Bodini, Alessandra ^a   Colnaghi, Maria I ^a   Ménard, Sylvie ^a   Balsari, Andrea ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G2; MYCOBACTERIUM ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL PROTECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MELANOMA CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

3T3 CELLS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; CANCER VACCINES; CELL LINEAGE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; INTERFERON TYPE I; INTRAMOLECULAR OXIDOREDUCTASES; LEUKEMIA VIRUS, MURINE; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PRECIPITIN TESTS; PREGNANCY PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0032843423     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<107::AID-IJC19>3.0.CO;2-T     Document Type: Article

References (27)

1. APOSTOLOPOULOS, V., OSINSKI, C. and MCKENZIE, I.F., MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nature (Med.), 4, 315-320 (1998).
2. BLOOM, M.B., PERRY-LALLEY, D., ROBBINS, P.F., LI, Y., EL-GAMIL, M., ROSENBERG, S.A. and YANG, J.C., Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. exp. Med., 185, 453-459 (1997).
3. BOON, T., CEROTTINI, J.-C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
4. CHEN, Y.-T., STOCKERT, E., TSANG, S., COPLAN, K.A. and OLD, L.J., Immunophenotyping of melanomas for tyrosinase: implication for vaccine development. Proc. nat. Acad. Sci. (Wash), 92, 8125-8129 (1995).
5. COULIE, P.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.P., RENAULD, J.-C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
6. HUANG, S.K.S., OKAMOTO, T., MORTON, D.L. and HOON, D.S.B., Antibody responses to melanoma/melanocyte autoantigens in melanoma patients. J. invest. Dermatol., 111, 662-667 (1998).
7. KANG, X., KAWAKAMI, Y., EL-GAMIL, M., WANG, R., SAKAGUCHI, K., YANNELLI, J.R., APPELLA, E., ROSENBERG, S.A. and ROBBINS, P.F., Identification of a tyrosinase epitope recognized by HLA-A-24-restricted, tumor-infiltrating lymphocytes. J. Immunol., 155, 1343-1348 (1995).
8. KAWAKAMI, Y., ELIYAHU, S., JENNINGS, C., SAKAGUCHI, K., KANG, X., SOUTHWOOD, S., ROBBINS, P.F., SETTE, A., APPELLA, E. and ROSENBERG, S.A., Recognition multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154, 3961-3968 (1995).
9. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. exp. Med., 180, 347-352 (1994).
10. KAWAKAMI, Y., ROBBINS, P.F., WANG, R.F., PARKHURST, M., KANG, X. and ROSENBERG, S.A., Tumor antigens recognized by T cells. The use of melanosomal proteins in the immunotherapy of melanoma. J. Immunother., 21, 237-246 (1998).
11. KEMP, E.H., GAWKRODGER, D.J., WATSON, P.F. and WEETMAN, A.P., Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin. exp. Immunol., 109, 495-500 (1997).
12. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
13. LEONG, S., MULLER, J., YETTER, R., GORELIK, E., TAKAMI, T. and HEARING, V.J., Expression and modulation of a retrovirus-associated antigen by murine melanoma cells. Cancer Res., 48, 4954-4958 (1988).
14. LI, M., XU, F., MULLER, J., HEARING, V.J. and GORELIK, E., Ecotropic c-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes. Int. J. Cancer, 76, 430-436 (1998).
15. MIOTTI, S., CANEVARI, S., MÉNARD, S., MEZZANZANICA, D., PORRO, G., PUPA, S.M., REGAZZONI, M., TAGLIABUE, E. and COLNAGHI, M.I., Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer, 39, 297-303 (1987).
16. OKAMOTO, T., IRIE, R.F., FUJII, S., HUANG, S.K.S., NIZZE, A.J., MORTON, D.L. and HOON, D.S.B., Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J. invest. Dermatol., 111, 1034-1039 (1998).
17. OLD, L.J. and CHEN, Y.T., New paths in human cancer serology. J. exp. Med., 187, 1163-1167 (1998).
18. SAHIN, U., TURECI, O., SCHMITT, H., COCHLOVIUS, B., JOHANNES, T., SCHMITS, R., STENNER, F., LUO, G., SCHOBERT, I. and PFREUNDSCHUH, M., Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. nat. Acad. Sci. (Wash.), 92, 11810-11813 (1995).
19. SCHREURS, M.W.J., DE BOER, A.J., SCHMIDT, A., FIGDOR, C.G. and ADEMA, G.J., Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100. Melanoma Res., 7, 463-470 (1997).
20. SFONDRINI, L., MORELLI, D., MÉNARD, S., MAIER, J.A.M., SINGH, M., MELANI, C., TERRAZZINI, N., COLOMBO, M.P., COLNAGHI, M.I. and BALSARI, A., Anti-tumor immunity induced by murine melanoma cells transduced with the Mycobacterium tuberculosis gene encoding the 38 kDa antigen. Gene Ther., 5, 247-252 (1998).
21. SNAPPER, C.M. and MOND, J.J., Towards a comprehensive view of immunoglobulin class switching. Immunol. Today, 14, 15-17 (1993).
22. THOMSON, T.M., MATTES, M.J., ROUX, L., OLD, L.J. and LLOYD, K.O., Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J. invest. Dermatol., 85, 169-174 (1985).
23. TRAVERSARI, C., CARBONE, G., DELLA TORRE, G., BERGOMI, M., PARMIANI, G. and SENSI, M.L., Expression of retrovirus-related, cytotoxic T lymphocyte- and transplantation-defined antigens in NIH/3T3 transfectants after a single passage in nude mice. J. Immunol., 142, 2887-2894 (1989).
24. TSUKAMOTO, K., JACKSON, I.J., URABE, K., MONTAGUE, P.M. and HEARING, V.J., A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J., 11, 519-526 (1992).
25. TUTING, T., STORKUS, W.J. and LOTZE, M.T., Gene-based strategies for the immunotherapy of cancer. J. mol. Med., 75, 478-491 (1997).
26. WANG, R.F., APPELLA, E., KAWAKAMI, Y., KANG, X. and ROSENBERG, S.A., Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. exp. Med., 184, 2207-2216 (1996).
27. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K.-H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanoma autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994).